(OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora ® Cream (calcipotriene and betamethasone dipropionate ...
(OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora ® Cream (calcipotriene and betamethasone dipropionate ...
MALVERN, Pa., Nov. 15, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora ® Cream ...
MALVERN, Pa., Nov. 15, 2024 /CNW/ -- Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics (“MC2") to commercialize Wynzora ® Cream ...